Emiac TechRs 0Last DayHighness Micro+Rs 8AllotmentPowerica Ltd+Rs 1ListingPropShare REIT+Rs 5KUpcomingFractal Analytics+Rs 35UpcomingZaggle Prepaid+Rs 8UpcomingEmiac TechRs 0Last DayHighness Micro+Rs 8AllotmentPowerica Ltd+Rs 1ListingPropShare REIT+Rs 5KUpcomingFractal Analytics+Rs 35UpcomingZaggle Prepaid+Rs 8Upcoming
MH

Medisync Healthcare IPO

Healthcare / Diagnostics - Medisync Healthcare operates a chain of diagnostic centers across Tier-2 and Tier-3 cities in North India

closedBSE SMEAI Tracked3 Mar - 7 Mar, 2026

Price Band

Rs 92 - 98

Cut-off: Rs 98 per share

Lot: 1,200 - Min Rs 1.18L

Open

03 Mar 2026

Last Day

07 Mar 2026

Allotment

10 Mar 2026

Listing

12 Mar 2026

GMP Today

25d ago

+Rs 18

+18.4% premium

Refresh in 5:00

Est. Listing Price

GMP Based

Rs 116

Issue Price + GMP (Dynamic)

Est. Profit (1 Lot)

GMP Based

+Rs 21,600

+18.4% (1200 shares)

Subscription

112.5x

Final

IPOGyani AI Engine - Live Prediction
+19.8%

Range: +15.8% to +23.8%

Confidence: High - 78%

Confidence Score - 78%

📈 GMP Trend Anchor Quality🧠 Sentiment 72/100📊 Sub 112.5x🏭 Healthcare / Diagnostics
Next refresh: 14m 18s-Updated: --:-- IST-Model: IPOGyani v2.1

Issue Details

Total Issue Size

Rs 28.4 Cr

Price Band

Rs 92 - 98

Fresh Issue vs OFS

Fresh Issue
Rs 28.4 Cr (100%)

Objects of the Issue (as per DRHP)

  • 1Opening 15 new diagnostic centers
  • 2Purchase of advanced diagnostic equipment
  • 3Technology upgradation for LIMS
  • 4Working capital requirements

Company Financials

Revenue Growth

29.0% YoY

FY23

Rs 32.5 Cr

FY24

Rs 42.8 Cr

FY25

Rs 55.2 Cr

Other Financial Metrics

EBITDA (FY25)

Rs 9.8 Cr

36.1% YoY

ROE

24.5%

Return on Equity

ROCE

21.2%

Return on Capital

Debt/Equity

0.28

Low Debt

2-Year CAGR

Revenue CAGR30.3%
Profit CAGR38.1%

P/E Ratio

21.5x

At upper band

Market Cap

~115 Cr

Post issue

MARKET SENTIMENT SCORE

-100
0
+100
+19.8
Bullish

Based on expert reviews, GMP trends & market signals

Expert Reviews & Opinions

Expert reviews for Medisync Healthcare IPO will appear here once available.

Reviews are summarized from YouTubers, analysts, news channels, and brokerage firms using AI.

Peer Comparison

Comparing with 2 listed peers
IPO P/E Ratio
21.5x
vs Peer Avg: 62.3x
IPO Market Cap
~115 Cr
Peer Avg: 18.4K Cr
IPO ROE
24.5%
vs Peer Avg: 20.4%
Peer Avg P/B
11.7x
Price-to-Book ratio
CompanyMarket CapRevenuePATP/EP/BROE
MH
Medisync HealthcareIPO
~115 CrRs 55.2 CrRs 6.1 Cr21.5x-24.5%
Dr Lal PathLabs22.5K Cr2.4K Cr385 Cr58.4x12.8x22.5%
Metropolis Healthcare14.2K Cr1.4K Cr215 Cr66.1x10.5x18.2%
Peer Average18.4K Cr1.9K Cr300 Cr62.3x11.7x20.4%

Quick Analysis

  • Medisync Healthcare's P/E of 21.5x is lower than the peer average of 62.3x, suggesting relatively attractive valuation.
  • ROE of 24.5% is above peer average (20.4%), indicating better return on equity.
  • Market cap post-listing would place Medisync Healthcare below peer average in terms of size.

* All peer data is from publicly available sources. Financial figures are latest reported annual numbers.

IPO Details

Open Date03 Mar 2026
Close Date07 Mar 2026
Allotment Date10 Mar 2026
Listing Date12 Mar 2026
Issue TypeBook Build Issue
Issue SizeRs 28.4 Cr
Fresh Issue28.4 Cr (100%)
OFSNil
Face ValueRs 10 per share
Price BandRs 92 - 98
Lot Size1,200 shares
Min Investment (Retail)Rs 1.18L
Listing ExchangeBSE SME

Company Information

Company NameMedisync Healthcare Ltd
IndustryHealthcare / Diagnostics
RegistrarBigshare Services
Lead ManagerUnistone Capital
Market Cap (Upper)~115 Cr
P/E (Upper Band)21.5x

About the Company

Medisync Healthcare operates a chain of diagnostic centers across Tier-2 and Tier-3 cities in North India. The company offers pathology, radiology, and preventive health checkup services.

Check Allotment Status

Check your Medisync Healthcare IPO allotment status on the registrar website.

R

Bigshare Services

IPO Registrar

Check Allotment Status

Disclaimer

IPOGyani is not SEBI registered and does not provide investment advice. All information is for educational purposes only.

AI predictions are probabilistic estimates based on historical data and market trends. Past performance is not indicative of future results.

GMP (Grey Market Premium) data is sourced from various unofficial channels and may not be accurate. Always verify from multiple sources.

Investors should do their own research (DYOR) and consult a SEBI registered advisor before investing.